What is Esperion Therapeutics's debt issuance proceeds?

Esperion Therapeutics (ESPR) reported debt issuance proceeds of $0 in Q4 2025.

How has Esperion Therapeutics's debt issuance proceeds changed year-over-year?

Esperion Therapeutics's debt issuance proceeds decreased by 100.0% year-over-year, from $24.93M to $0.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Esperion Therapeutics ESPR Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

AmgenAMGN

$3.96B—

OrganonOGN

$0-100%

Beam TherapeuticsBEAM

$93.89M—

BioCryst PharmaceuticalsBCRX

$400M—

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfDebt.

The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's debt issuance proceeds?: Esperion Therapeutics (ESPR) reported debt issuance proceeds of $0 in Q4 2025.
How has Esperion Therapeutics's debt issuance proceeds changed year-over-year?: Esperion Therapeutics's debt issuance proceeds decreased by 100.0% year-over-year, from $24.93M to $0.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.